000 01678 a2200433 4500
005 20250514040526.0
264 0 _c20021224
008 200212s 0 0 eng d
022 _a0160-2446
024 7 _a10.1097/00005344-200208000-00002
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFontaine, David
245 0 0 _aChronic hydroxymethylglutaryl coenzyme a reductase inhibition and endothelial function of the normocholesterolemic rat: comparison with angiotensin-converting enzyme inhibition.
_h[electronic resource]
260 _bJournal of cardiovascular pharmacology
_cAug 2002
300 _a172-80 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xtoxicity
650 0 4 _aAnimals
650 0 4 _aCholesterol
_xblood
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aEndothelium, Vascular
_xdrug effects
650 0 4 _aEnzyme-Linked Immunosorbent Assay
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xtoxicity
650 0 4 _aMale
650 0 4 _aMuscle, Smooth, Vascular
_xdrug effects
650 0 4 _aPravastatin
_xtoxicity
650 0 4 _aRamipril
_xtoxicity
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aVasodilation
_xdrug effects
700 1 _aFontaine, Jeanine
700 1 _aDupont, Isabelle
700 1 _aDessy, Chantal
700 1 _aPiech, Alina
700 1 _aCarpentier, Yvon
700 1 _aBerkenboom, Guy
773 0 _tJournal of cardiovascular pharmacology
_gvol. 40
_gno. 2
_gp. 172-80
856 4 0 _uhttps://doi.org/10.1097/00005344-200208000-00002
_zAvailable from publisher's website
999 _c12019707
_d12019707